Serendipity in antiseizure medication discovery: Unveiling accidental breakthroughs in epilepsy treatments

Serendipity has played a significant role in the discovery of several key antiseizure medications, when unexpected observations have led to groundbreaking treatments. This narrative review explores the historical context of serendipitous discoveries in epilepsy pharmacotherapy, highlighting how drugs such as potassium bromide, phenobarbital, valproic acid, and levetiracetam emerged through unintended observations rather than rational drug design. Whereas early antiseizure medications were often identified by chance, modern drug development has shifted toward a target-based approach, leveraging advances in molecular biology and high-throughput screening to identify promising therapeutic agents. Despite this evolution, serendipity remains relevant, as unanticipated findings continue to shape epilepsy treatment and expand the therapeutic landscape. By analyzing past discoveries, this review underscores the interplay between structured scientific inquiry and chance observations, emphasizing the need for prepared minds to recognize and capitalize on unexpected breakthroughs in epilepsy drug development.